{"title":"队列研究发现治疗多动症的药物可降低死亡风险","authors":"","doi":"10.1002/pu.31178","DOIUrl":null,"url":null,"abstract":"<p>Children and adults with attention-deficit hyperactivity disorder (ADHD) who initiated medication treatment had significantly lower 2-year mortality rates compared with ADHD patients who did not initiate medication, a cohort study has found. The difference in mortality rates was greater for deaths due to unnatural causes such as accidental poisoning and suicide.</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"35 7","pages":"3"},"PeriodicalIF":0.0000,"publicationDate":"2024-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Cohort study finds medications for ADHD reduce mortality risk\",\"authors\":\"\",\"doi\":\"10.1002/pu.31178\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Children and adults with attention-deficit hyperactivity disorder (ADHD) who initiated medication treatment had significantly lower 2-year mortality rates compared with ADHD patients who did not initiate medication, a cohort study has found. The difference in mortality rates was greater for deaths due to unnatural causes such as accidental poisoning and suicide.</p>\",\"PeriodicalId\":22275,\"journal\":{\"name\":\"The Brown University Psychopharmacology Update\",\"volume\":\"35 7\",\"pages\":\"3\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-06-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Brown University Psychopharmacology Update\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/pu.31178\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Brown University Psychopharmacology Update","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/pu.31178","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Cohort study finds medications for ADHD reduce mortality risk
Children and adults with attention-deficit hyperactivity disorder (ADHD) who initiated medication treatment had significantly lower 2-year mortality rates compared with ADHD patients who did not initiate medication, a cohort study has found. The difference in mortality rates was greater for deaths due to unnatural causes such as accidental poisoning and suicide.